Search details
1.
Atezolizumab monotherapy versus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis from a randomised, controlled, phase 3 study.
Lancet Oncol
; 25(1): 46-61, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-38101431
2.
Targeting HER2-mutant metastatic cervical cancer with neratinib: Final results from the phase 2 SUMMIT basket trial.
Gynecol Oncol
; 181: 162-169, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-38211393
3.
The prognostic value of the previous nephrectomy in pretreated metastatic renal cell carcinoma receiving immunotherapy: a sub-analysis of the Meet-URO 15 study.
J Transl Med
; 20(1): 435, 2022 09 30.
Article
in English
| MEDLINE | ID: mdl-36180954
4.
Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial.
Lancet
; 395(10236): 1547-1557, 2020 05 16.
Article
in English
| MEDLINE | ID: mdl-32416780
5.
Real-life clinical practice results with vinflunine in patients with relapsed platinum-treated metastatic urothelial carcinoma: an Italian multicenter study (MOVIE-GOIRC 01-2014).
BMC Cancer
; 17(1): 493, 2017 Jul 19.
Article
in English
| MEDLINE | ID: mdl-28724419
6.
CD99 Expression and Prognostic Impact in Glioblastoma: A Single-Center Cohort Study.
Cells
; 13(7)2024 Mar 29.
Article
in English
| MEDLINE | ID: mdl-38607036
7.
Analysis of PD-L1 and CD3 Expression in Glioblastoma Patients and Correlation with Outcome: A Single Center Report.
Biomedicines
; 11(2)2023 Jan 22.
Article
in English
| MEDLINE | ID: mdl-36830847
8.
Compassionate Use Program of Ipilimumab and Nivolumab in Intermediate or Poor Risk Metastatic Renal Cell Carcinoma: A Large Multicenter Italian Study.
Cancers (Basel)
; 14(9)2022 05 04.
Article
in English
| MEDLINE | ID: mdl-35565422
9.
The prognostic value of baseline and early variations of peripheral blood inflammatory ratios and their cellular components in patients with metastatic renal cell carcinoma treated with nivolumab: The Δ-Meet-URO analysis.
Front Oncol
; 12: 955501, 2022.
Article
in English
| MEDLINE | ID: mdl-36212433
10.
MDM2 gene amplification as selection tool for innovative targeted approaches in PD-L1 positive or negative muscle-invasive urothelial bladder carcinoma.
J Clin Pathol
; 75(1): 39-44, 2022 Jan.
Article
in English
| MEDLINE | ID: mdl-33144356
11.
Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study.
J Pers Med
; 12(5)2022 Apr 30.
Article
in English
| MEDLINE | ID: mdl-35629151
12.
Inflammatory indices and clinical factors in metastatic renal cell carcinoma patients treated with nivolumab: the development of a novel prognostic score (Meet-URO 15 study).
Ther Adv Med Oncol
; 13: 17588359211019642, 2021.
Article
in English
| MEDLINE | ID: mdl-34046089
13.
Immune-related Adverse Events and Survival in Solid Tumors Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.
J Immunother
; 43(1): 1-7, 2020 01.
Article
in English
| MEDLINE | ID: mdl-31574022
14.
Impact of influenza syndrome and flu vaccine on survival of cancer patients during immunotherapy in the INVIDIa study.
Immunotherapy
; 12(2): 151-159, 2020 02.
Article
in English
| MEDLINE | ID: mdl-32089035
15.
Prognostic and predictive value of histogram analysis in patients with non-small cell lung cancer refractory to platinum treated by nivolumab: A multicentre retrospective study.
Eur J Radiol
; 118: 251-256, 2019 Sep.
Article
in English
| MEDLINE | ID: mdl-31439251
16.
Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: the Italian expanded access program.
J Immunother Cancer
; 7(1): 99, 2019 04 03.
Article
in English
| MEDLINE | ID: mdl-30944023
17.
INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a transversal challenge. The INVIDIa study.
Immunotherapy
; 10(14): 1229-1239, 2018 10.
Article
in English
| MEDLINE | ID: mdl-30326787
18.
Radical treatment of oligometastatic non-small cell lung cancer: Ready for prime time?
Eur J Cancer
; 79: 149-151, 2017 07.
Article
in English
| MEDLINE | ID: mdl-28494405
19.
First-line dose-dense chemotherapy with docetaxel, cisplatin, folinic acid and 5-fluorouracil (DCF) plus panitumumab in patients with locally advanced or metastatic cancer of the stomach or gastroesophageal junction: final results and biomarker analysis from an Italian oncology group for clinical research (GOIRC) phase II study.
Oncotarget
; 8(67): 111795-111806, 2017 Dec 19.
Article
in English
| MEDLINE | ID: mdl-29340092
20.
New developments in the treatment of chemotherapy-induced neutropenia: focus on balugrastim.
Ther Clin Risk Manag
; 12: 1009-15, 2016.
Article
in English
| MEDLINE | ID: mdl-27445479